Developing new effective treatments is essential in defeating MND. This may come through new drug discoveries or re-purposing drugs in platform trials.
Better-Designed, More Inclusive Clinical Trials
Only 8% of MND patients in Ireland are eligible to partake in clinical trials. We must change this now.
New Objective Outcome Measures
Supporting the development of more objective outcome measures will ensure more accurate assessment of patient disease progression throughout clinical trials. This will inherently assist in the development of more effective treatments for MND.
A Time for Optimism
Our objective is to have the right drug in the right dose, for the right patient at the right time. We are almost there. MND is not an untreatable disease. It is an underfunded disease.
Prof. Orla Hardiman (Research Motor Neurone)
Who We Are
Motor Neurone Disease is relentless...but so are we.